GenoFocus Inc (187420) — Cash Flow Reinvestment Rate

Latest as of December 2025: 7.15x

GenoFocus Inc (187420) has a Cash Flow Reinvestment Rate of 7.15x as of December 2025, reinvesting ₩2.06 Billion (capex ₩138.88 Million plus investments ₩-1.92 Billion) from operating cash flow of ₩288.09 Million. Check 187420 cash flow quality score to evaluate the quality of earnings relative to operating cash generation.

Reinvestment Rate

7.15x
(Capex + Investments) / Operating CF

Total Reinvested

₩2.06 Billion
Capex + Investments

Operating Cash Flow

₩288.09 Million
KRW

Capital Expenditures

₩138.88 Million
KRW

GenoFocus Inc Cash Flow Reinvestment Rate (2015–2025)

Historical reinvestment intensity for GenoFocus Inc across 6 annual periods. Explore 187420 long-term asset investment ratio to see how much of total assets are deployed in long-term investments.

Annual Cash Flow Reinvestment Rate for GenoFocus Inc (2015–2025)

Year-by-year capital reinvestment analysis for GenoFocus Inc. For live market cap and broader valuation context, see market value of GenoFocus Inc.

Year Reinvestment Rate Total Reinvested (KRW) Operating CF Capex YoY Change
2025 2.28x ₩8.00 Billion ₩3.50 Billion ₩1.08 Billion ▼ -8.4%
2024 2.49x ₩7.15 Billion ₩2.87 Billion ₩699.16 Million ▼ -75.3%
2018 10.10x ₩15.80 Billion ₩1.56 Billion ₩7.42 Billion ▼ -4.5%
2017 10.58x ₩14.43 Billion ₩1.36 Billion ₩2.06 Billion ▼ -85.6%
2016 73.60x ₩37.98 Billion ₩516.09 Million ₩5.46 Billion ▲ +2249.8%
2015 3.13x ₩8.94 Billion ₩2.85 Billion ₩8.14 Billion
Cash Flow Reinvestment Rate = (ABS(Capex) + ABS(Investments)) / Operating Cash Flow